Better Understanding the Link between Myasthenia Gravis...
February 1, 2016 - Featured , In the News / Politics By: Jacqueline Chirico, PharmD Candidate c/o 2016 – Myasthenia gravis is an autoimmune disorder in which an antibody-mediated attack is directed against the nicotinic acetylcholine (ACh) receptors at neuromuscular junctions.1 About 85% of people with myasthenia gravis have antibodies to the ACh receptor, while the remaining 15% are seronegative. Although one is more common than… |
|
Optimizing Drug Safety in the Operating Room...
February 1, 2016 - Featured , In the News / Politics By: Maryam Ahmed, PharmD Candidate c/o 2016 – While hospitals are a place where people can get their ailments cured, there is still room for improvement. According to the Institute of Medicine, over 1.5 million Americans are injured in hospitals each year.1 Hospital protocols are implemented to keep these errors to a minimum in order… |
|
Pharmacists’ Standpoint on Possible Changes to Profes...
February 1, 2016 - Featured , Professional Advice / Opinions By: Victoria Chirico, PharmD Candidate c/o 2018 – From I-STOP surveillance to vaccine administration, many changes have been made in the world of pharmacy, with more to come. Whether these changes are for the better or worse, they define the roles of a pharmacist in our world today. As the role of a pharmacist is… |
|
Review of Thalidomide in Memory of Dr. Frances Oldham K...
February 1, 2016 - Clinical , Featured By: Kevin J. Choi, PharmD Candidate c/o 2016 – “Morning Sickness” – we have all heard of this term being associated with thalidomide, a drug particularly recognized for its antiemetic effect, but also for its notorious teratogenicity. However, it is worth re-familiarizing ourselves with the nature of the drug itself (and the clinical threats that… |
|
The Importance of Counseling and its Impact on Medicati...
February 1, 2016 - Featured , Professional Advice / Opinions By: Sherin Pathickal, PharmD Candidate c/o 2016, Rahul Patel, PharmD Candidate c/o 2017, and Sierra Swaby, PharmD Candidate c/o 2020 – The pharmacy profession is changing within the healthcare system by making pharmaceutical care one of its main responsibilities. Pharmaceutical care does not adhere to the way that pharmacists have traditionally practiced, but instead requires… |
|
The Reality behind a “Stone Heart”...
February 1, 2016 - Clinical , Featured By: Dimitrios Savva, PharmD c/o 2016 – Digoxin is a cardiac glycoside used in the treatment of atrial fibrillation (Afib) and heart failure. Digoxin inhibits sodium-potassium ATPase, leading to an increase in intracellular sodium which in turn inhibits sodium-dependent calcium transport out of the cytoplasm and ultimately results in an increase in intracellular calcium.1 The… |